Abstract: Among other things, the present disclosure provides various technologies including chirally controlled oligonucleotide compositions and technologies for manufacturing and using such oligonucleotide compositions. In some embodiments, the present disclosure provides technologies useful for preventing or treating various conditions, disorders or diseases, e.g., Duchenne Muscular Dystrophy.
| # | Name | Date |
|---|---|---|
| 1 | 202417066992-STATEMENT OF UNDERTAKING (FORM 3) [04-09-2024(online)].pdf | 2024-09-04 |
| 2 | 202417066992-REQUEST FOR EXAMINATION (FORM-18) [04-09-2024(online)].pdf | 2024-09-04 |
| 3 | 202417066992-POWER OF AUTHORITY [04-09-2024(online)].pdf | 2024-09-04 |
| 4 | 202417066992-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [04-09-2024(online)].pdf | 2024-09-04 |
| 5 | 202417066992-FORM 18 [04-09-2024(online)].pdf | 2024-09-04 |
| 6 | 202417066992-FORM 1 [04-09-2024(online)].pdf | 2024-09-04 |
| 7 | 202417066992-DRAWINGS [04-09-2024(online)].pdf | 2024-09-04 |
| 8 | 202417066992-DECLARATION OF INVENTORSHIP (FORM 5) [04-09-2024(online)].pdf | 2024-09-04 |
| 9 | 202417066992-COMPLETE SPECIFICATION [04-09-2024(online)].pdf | 2024-09-04 |
| 10 | 202417066992-Proof of Right [20-09-2024(online)].pdf | 2024-09-20 |
| 11 | 202417066992-FORM 3 [19-02-2025(online)].pdf | 2025-02-19 |